UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under
Section 12(g) of the Securities Exchange Act
of 1934 or Suspension of Duty to File Reports Under Sections
13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 0-13008
MEDICINE SHOPPE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
1100 N. Lindbergh Boulevard, St. Louis, Missouri 63132
(314) 993-6000
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
Common Stock, $0.01 Par Value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or
suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [ ]
Approximate number of holders of record as of the
certification or notice date: 1
Pursuant to the requirements of the Securities
Exchange Act of 1934, Medicine Shoppe International, Inc. has
caused this certification/notice to be signed on its behalf by
the undersigned duly authorized person.
DATE: November 13, 1995 By: /s/ Jeffrey A. Brimer
Jeffrey A. Brimer
Vice President, General
Counsel and Secretary
